stockrow
Friday 6 November 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024.
- Revenue
- +53.1%
- EPS
- +56.9%
- Free cash flow
- +86.7%
- Total debt
- +7.13%
Quarter to September 2026, against a year earlier
16.56
0.88
+5.61%
Follow RCEL
Alert me
| Jun '19 | Dec '19 | Jun '20 | Dec '20 | Jun '21 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | 2 | 3 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 22.42 | 17.45 | 21.39 | 4.68 | 6.86 | 5.16 | 1.34 |
Altman Z-Score |
42.97 | 56.99 | 33.18 | 16.65 | 26.51 | 13.90 | 3.97 | 0.01 | (4.65) | (11.21) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(12.52) | (23.16) | 2.05 | (2.12) | 11.12 | 9.47 | 1.17 | (4.60) | (16.38) | (32.20) |
Beneish M-Score |
— | — | — | — | — | — | 0.20 | (3.01) | (2.03) | (4.09) |
P/Operating CF |
0.00 | (199.67) | (104.76) | (70.80) | (127.69) | 39.14 | (46.93) | (31.68) | (40.99) | (17.68) |
P/B ratio |
0.00 | 10.05 | 8.56 | 6.74 | 4.41 | 2.85 | 1.90 | 7.01 | 73.63 | 0.00 |
Price to Tangible BV |
0.00 | 10.09 | 8.61 | 6.79 | 4.43 | 2.87 | 1.91 | 7.09 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 19.20 | 13.73 | 15.34 | 2.41 | 5.90 | 5.27 | 2.27 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.45 | (46.18) | (44.81) | (25.69) | (126.32) | (38.92) | (4.34) | (7.78) | (6.92) | (5.21) |
EV/FCF |
0.43 | (44.31) | (44.34) | (24.09) | (107.07) | (38.01) | (4.20) | (7.48) | (5.80) | (4.92) |
Quick Ratio |
5.09 | 5.09 | 9.89 | 9.90 | 16.01 | 16.08 | 7.83 | 7.33 | 2.36 | 0.44 |
Current Ratio |
5.50 | 5.50 | 10.17 | 10.17 | 16.42 | 16.42 | 8.18 | 7.88 | 2.83 | 0.57 |
Net Debt/EBITDA |
0.83 | 0.65 | 1.78 | 1.56 | 4.30 | 4.03 | 3.01 | 1.47 | (0.11) | (0.60) |
Debt/Assets |
0.15% | 0.15% | 0.00% | 2.98% | 0.00% | 1.26% | 0.93% | 35.66% | 53.00% | 76.22% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.01 | 0.01 | 0.81 | 9.39 | (2.58) |
Asset Turnover |
0.25 | 0.21 | 0.26 | 0.17 | 0.28 | 0.23 | 0.31 | 0.48 | 0.67 | 1.05 |
Operating CF/Net income |
0.79 | 0.78 | 0.54 | 0.54 | 0.97 | 0.97 | 0.72 | 1.07 | 0.79 | 0.64 |
Capex/Depreciation |
(4.77) | 0.00 | (1.82) | 0.00 | (1.64) | (0.09) | (0.92) | (2.19) | (8.14) | (0.70) |
Interest Coverage |
(920.36) | (192.77) | (1,272.52) | (2,824.55) | (1,205.59) | (3,364.12) | (1,663.31) | (29.90) | (10.53) | (8.71) |
| (138.34%) | (117.92%) | (90.09%) | (58.05%) | (28.27%) | (22.98%) | (26.61%) | (52.89%) | (230.96%) | 799.72% | |
| (114.36%) | (96.61%) | (77.66%) | (50.97%) | (25.57%) | (21.18%) | (23.83%) | (33.71%) | (64.64%) | (71.40%) | |
ROIC |
(1,478.09%) | 0.00% | 0.00% | 0.00% | (352.10%) | (142.98%) | (263.35%) | 0.00% | (324.79%) | (334.18%) |
Return on Tangible Assets |
(114.83%) | (118.91%) | (58.34%) | (56.50%) | (23.04%) | (22.74%) | (34.20%) | (38.17%) | (131.98%) | 261.83% |
Average Days of Receivables |
141.17 | 138.52 | 62.24 | 64.16 | 92.44 | 98.43 | 46.80 | 56.01 | 66.95 | 46.31 |
Research and Development Expense of Revenue |
186.39% | 186.39% | 64.25% | 59.32% | 50.69% | 50.69% | 40.26% | 41.52% | 31.69% | 29.10% |
Selling, General and Administrative Expense of Revenue |
463.54% | 462.84% | 341.66% | 346.59% | 126.78% | 126.78% | 131.44% | 130.88% | 142.24% | 112.43% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.10 |
Share Based Compensation of Revenue |
35.31% | 0.00% | 115.59% | 0.00% | 19.38% | 12.27% | 20.33% | 16.72% | 21.01% | 13.29% |
Graham Net Nets |
0.00 | 0.09 | 0.11 | 0.14 | 0.22 | 0.27 | 0.46 | 0.12 | (0.05) | (0.39) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.84 |
Earnings Yield |
(18.40%) | (12.64%) | (21.84%) | (8.80%) | (5.80%) | (8.62%) | (16.54%) | (10.28%) | (18.67%) | (50.55%) |
Free Cash Flow Yield |
0.00% | (2.04%) | (1.99%) | (3.55%) | (0.73%) | (1.89%) | (12.22%) | (11.49%) | (17.61%) | (34.36%) |
Revenue per Share |
0.43 | 0.44 | 0.70 | 0.70 | 1.29 | 1.29 | 1.38 | 1.98 | 2.48 | 2.57 |
Operating CF per Share |
(1.55) | (1.55) | (1.12) | (1.12) | (1.14) | (1.14) | (0.76) | (1.50) | (1.89) | (1.12) |
Capex per Share |
(0.10) | 0.00 | (0.04) | 0.00 | (0.05) | (0.01) | (0.02) | (0.05) | (0.35) | (0.06) |
Free Cash Flow per Share |
(1.65) | (1.55) | (1.16) | (1.12) | (1.19) | (1.15) | (0.78) | (1.55) | (2.25) | (1.18) |
Cash per Share |
1.64 | 1.61 | 3.64 | 3.64 | 4.89 | 4.89 | 3.17 | 3.51 | 1.39 | 0.65 |
Shareholders Equity per Share |
1.71 | 1.65 | 3.57 | 3.57 | 5.10 | 5.10 | 3.39 | 1.94 | 0.17 | (0.60) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.71 | 1.65 | 3.57 | 3.57 | 5.10 | 5.10 | 3.39 | 1.94 | 0.17 | (0.60) |
Free Cash Flow |
(20.94) | (19.66) | (23.59) | (22.75) | (27.07) | (26.03) | (19.61) | (39.39) | (58.11) | (32.83) |
Working Capital |
20.24 | 19.86 | 70.68 | 70.68 | 113.94 | 113.94 | 76.77 | 90.81 | 36.84 | (27.19) |
Capital Expenditures |
(1.28) | (1.28) | (0.85) | (0.85) | (1.17) | (0.13) | (0.52) | (1.38) | (9.17) | (1.64) |
Net Current Asset Value |
20.20 | 19.39 | 68.33 | 68.33 | 111.48 | 111.48 | 73.93 | 41.42 | (18.21) | (37.55) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.23 | 0.00 | 0.06 | 0.00 | 0.04 | 0.00 | 0.02 | 0.03 | 0.14 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.21 | 0.34 | 0.26 | 0.49 | 0.49 | 0.47 | 0.34 | 0.11 | 0.27 |
Cash ROIC |
(49.26%) | (47.62%) | (16.13%) | (15.30%) | (11.95%) | (11.41%) | (11.89%) | (22.14%) | (70.33%) | (73.76%) |
Accounts Receivable Turnover |
1.79 | 2.61 | 6.31 | 5.78 | 5.90 | 3.82 | 5.60 | 8.28 | 6.60 | 6.86 |
Accounts Payable Turnover |
0.57 | 0.54 | 1.24 | 0.69 | 1.60 | 1.91 | 1.97 | 2.29 | 1.80 | 1.68 |
Inventory Turnover |
1.51 | 1.62 | 3.18 | 2.64 | 4.29 | 3.61 | 3.20 | 2.02 | 1.41 | 1.80 |
Average Days of Payables |
1,211.09 | 143.27 | 531.97 | 531.97 | 191.43 | 191.43 | 181.38 | 177.95 | 252.62 | 255.59 |
Days of Inventory on Hand |
227.39 | 223.14 | 138.12 | 138.12 | 101.05 | 101.05 | 128.39 | 262.54 | 291.75 | 197.59 |
Average Receivables |
3.07 | 2.11 | 2.26 | 2.47 | 4.96 | 7.64 | 6.15 | 6.05 | 9.74 | 10.44 |
Average Payables |
2.12 | 2.25 | 2.40 | 4.33 | 3.73 | 3.12 | 3.06 | 3.40 | 5.04 | 7.63 |
Average Inventory |
0.81 | 0.75 | 0.93 | 1.13 | 1.39 | 1.65 | 1.89 | 3.86 | 6.43 | 7.10 |
Average Assets |
21.64 | 26.03 | 54.12 | 82.46 | 103.98 | 125.50 | 111.88 | 104.95 | 95.68 | 68.05 |
Average Common Equity |
17.89 | 21.32 | 46.65 | 72.40 | 94.03 | 115.66 | 100.20 | 66.90 | 26.78 | (6.08) |
Columns are period end dates · fundamentals updated 5 Nov 2026